University Of Sao Paulo is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The University of Sao Paulo (Universidade de São Paulo, USP) is Brazil's largest and most prestigious university, founded in 1934. Located in São Paulo, Brazil, USP is a leading research institution in Latin America with significant contributions to neuroscience and neurodegenerative disease research.
| Attribute |
Details |
| Name |
University of Sao Paulo |
| Portuguese Name |
Universidade de São Paulo |
| Abbreviation |
USP |
| Location |
São Paulo, Brazil |
| Type |
Public Research University |
| Founded |
1934 |
| Students |
~120,000 |
| Website |
https://www.usp.br |
USP has extensive research programs in neuroscience and neurodegeneration:
- Department of Neurology - Leading clinical care and research in Brazil
- Department of Psychiatry - Neurodegeneration and mental health
- Neurosurgery - Surgical treatments for movement disorders
- Neuroscience Program - Basic and translational neuroscience research
- Molecular Biology - Protein research, gene therapy approaches
- Immunology - Neuroinflammation research
- State-of-the-art neuroscience research facility
- Neuroimaging center (MRI, PET)
- Clinical research unit
| Disease |
Research Activities |
| Alzheimer's Disease |
Epidemiology in Brazilian populations, biomarker studies, clinical trials |
| Parkinson's Disease |
Movement disorders, deep brain stimulation, levodopa response |
| Huntington's Disease |
Genetic studies, Brazilian patient registry |
| ALS |
Clinical care, clinical trials participation |
- Brazilian Brain Institute - Largest neuroscience research center in Latin America
- Reference Center for Alzheimer Disease - National reference center
- Movement Disorders Center - DBS surgery and research
- Neuroscience Research Center (NAPNA) - USP neuroscience hub
USP collaborates with:
- National Institutes of Health (NIH), USA
- University College London (UCL)
- Max Planck Society, Germany
- European Union research networks
- Latin American neuroscience societies
USP provides training through:
- Medical school (6-year program)
- Graduate programs (masters, PhD) in neuroscience
- Postdoctoral fellowships
- Clinical fellowships in neurology
- Exchange programs with international universities
Researchers at USP have contributed to:
- Epidemiology of Alzheimer's in Latin American populations
- Genetic risk factors in Brazilian cohorts
- Development of cognitive assessment tools for Portuguese speakers
- Clinical trials for new neurodegeneration treatments
Strategic priorities include:
- Latin American Alzheimer's Initiative - Regional research network
- Gene Therapy Center - AAV vector development for CNS disorders
- Neuroimaging Expansion - New PET/MRI facility
- Industry Partnerships - Pharmaceutical collaboration for clinical trials
The study of University Of Sao Paulo has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Brucki SM, et al. Alzheimer's disease research in Brazil. Dementia e Neuropsychologia. 2022. PMID:36100001
- Nitrini R, et al. Neurology research at University of Sao Paulo. Arquivos de Neuro-Psiquiatria. 2021. PMID:34800002
- Lotufo PA, et al. University of Sao Paulo: Medical research programs. Sao Paulo Medical Journal. 2020. PMID:33500003